More tools:Markets·Screener·Research·Chat

Aehr Test Systems (AEHR) Financial Statements

Aehr Test Systems
SIC 3825 · INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS
FIGI BBG001SB1CS4
XNAS · usd
90.79▲ 4.53 (5.25%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close86.26
Day's Range89.34 – 94.63
52-Week Range18.70 – 147.40
Volume3.9M
Avg Volume2.6M
Share Statistics
Shares Outstanding
Employees136
ExchangeXNAS
Listed1997-08-15
Share count as of July 20, 2026
Loading Income Statement…
Key questions about Aehr Test Systems (AEHR)
What is Aehr Test Systems's Market Cap?
Aehr Test Systems's Market Cap is $3.0B, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's Price / Sales?
Aehr Test Systems's Price / Sales is 59.2×, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's Revenue (TTM)?
Aehr Test Systems's Revenue (TTM) is $50.0M, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's Net Income (TTM)?
Aehr Test Systems's Net Income (TTM) is -$7.1M, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's EBITDA?
Aehr Test Systems's EBITDA is -$11.3M, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's Diluted EPS (TTM)?
Aehr Test Systems's Diluted EPS (TTM) is -0.22, based on as-reported figures from SEC (XBRL) filings.
What is Aehr Test Systems's EBITDA Margin?
Aehr Test Systems's EBITDA Margin is -22.7%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMay 29, 2026Feb 27, 2026Nov 28, 2025Aug 29, 2025May 30, 2025Feb 28, 2025Nov 29, 2024Aug 30, 2024May 31, 2024Feb 29, 2024Nov 30, 2023Aug 31, 2023May 31, 2023Feb 28, 2023Nov 30, 2022Aug 31, 2022May 31, 2022
CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue
YoY growth+33.7%-43.7%-26.5%-16.4%-15.1%
Cost of Revenue
Gross profit
% of revenue42.6%32.7%25.7%33.9%30.3%
Operating expenses:
Research and Development Expense
Selling, General and Administrative Expense
Restructuring charges
Total operating expenses
% of revenue49.0%73.7%72.8%71.0%53.1%
Income (loss) from operations
% of revenue-6.4%-41.0%-47.0%-37.1%-22.7%
Net Interest Income
Non-Operating Income (Expense)
Income (loss) before income tax benefit
Income Tax Expense
Net income (loss)
% of revenue7.4%-31.1%-32.7%-19.0%-20.6%
Basic net income (loss) per share
Diluted net income (loss) per share